Corient Private Wealth Portfolio holdings
Corient Private Wealth is the U.S. wealth management business that grew out of Canadian asset manager CI Financial's push into American wealth advisers. It was called CI Private Wealth until 2023, when it took the name Corient, a play on the words "client" and "oriented." Its advisers typically manage client portfolios by hiring and replacing outside investment managers and choosing individual securities, guided by an investment committee. Clients include individuals, among them high-net-worth individuals, as well as trusts, estates and charitable organizations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$313M |
| 2 |
RTX Corp
RTX
|
+$247M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 4 |
Quanta Services
PWR
|
+$126M |
| 5 |
Marvell Technology
MRVL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$449M |
| 2 |
NVIDIA
NVDA
|
+$392M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$375M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$331M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.68% |
| 2 | Technology | 19.67% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 7.58% |
| 5 | Healthcare | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.1B
| $1.03M | ﹤0.01% |
45,298
-9,218
| -17% | -$209K |
2024 Q3
7 quarters
|
|
1802
Goldman Sachs BDC
GSBD
$1.01B
| $1.03M | ﹤0.01% |
108,143
-3,774
| -3% | -$35.1K |
2022 Q4
14 quarters
|
|
1803
Schwab 1000 Index ETF
SCHK
$5.67B
| $1.02M | ﹤0.01% |
28,252
-14,383
| -34% | -$502K |
2022 Q4
14 quarters
|
|
1804
iShares Short Maturity Bond ETF
NEAR
$5.13B
| $1.02M | ﹤0.01% |
20,086
-243,304
| -92% | -$12.3M |
2025 Q2
4 quarters
|
|
1805
Tenaris
TS
$30.4B
| $1.02M | ﹤0.01% |
18,328
+3,588
| +24% | +$218K |
2022 Q4
14 quarters
|
|
1806
Lamb Weston
LW
$7.45B
| $1.02M | ﹤0.01% |
23,522
-54,119
| -70% | -$2.33M |
2022 Q4
14 quarters
|
|
1807
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.58B
| $1.01M | ﹤0.01% |
15,680
-1,080
| -6% | -$69.3K |
2022 Q4
14 quarters
|
|
1808
Protolabs
PRLB
$1.64B
| $1.01M | ﹤0.01% |
12,427
+1,723
| +16% | +$121K |
2026 Q1
1 quarter
|
|
1809
iShares US Treasury Bond ETF
GOVT
$42.9B
| $1.01M | ﹤0.01% |
44,415
-2,762
| -6% | -$62.9K |
2023 Q2
12 quarters
|
|
1810
Sabesp
SBS
$16B
| $1.01M | ﹤0.01% |
174,844
-7,961
| -4% | -$48.2K |
2025 Q3
3 quarters
|
|
1811
Stoke Therapeutics
STOK
$1.7B
| $1.01M | ﹤0.01% |
+30,823
| New | +$989K |
2026 Q2
0 quarters
|
|
1812
State Street SPDR S&P 500 ESG ETF
EFIV
$1.02B
| $1.01M | ﹤0.01% |
13,789
-2,092
| -13% | -$147K |
2022 Q4
14 quarters
|
|
1813
iShares Global 100 ETF
IOO
$9.05B
| $1.01M | ﹤0.01% |
7,359
-2,731
| -27% | -$372K |
2022 Q4
14 quarters
|
|
1814
Ascendis Pharma A/S
ASND
$16.5B
| $1.01M | ﹤0.01% |
3,768
+385
| +11% | +$89.9K |
2024 Q4
6 quarters
|
|
1815
State Street SPDR S&P Regional Banking ETF
KRE
$4.3B
| $1M | ﹤0.01% |
13,421
+1,765
| +15% | +$124K |
2023 Q1
13 quarters
|
|
1816
Nomura Holdings
NMR
$27.4B
| $1M | ﹤0.01% |
114,118
+10,088
| +10% | +$83.9K |
2022 Q4
14 quarters
|
|
1817
Kulicke & Soffa
KLIC
$3.88B
| $1000K | ﹤0.01% |
7,474
+3,082
| +70% | +$302K |
2026 Q1
1 quarter
|
|
1818
Blue Owl Technology Finance Corp
OTF
$4.36B
| $999K | ﹤0.01% |
96,563
+66,363
| +220% | +$738K |
2025 Q4
2 quarters
|
|
1819
Cullinan Oncology
CGEM
$967M
| $999K | ﹤0.01% |
54,877
+26,992
| +97% | +$401K |
2026 Q1
1 quarter
|
|
1820
Apogee Enterprises
APOG
$945M
| $999K | ﹤0.01% |
21,830
+10,966
| +101% | +$410K |
2026 Q1
1 quarter
|
|
1821
Argan
AGX
$4.83B
| $997K | ﹤0.01% |
+1,249
| New | +$831K |
2026 Q2
0 quarters
|
|
1822
First Trust NYSE Arca Biotechnology Index Fund
FBT
$3.06B
| $996K | ﹤0.01% |
+4,016
| New | +$865K |
2026 Q2
0 quarters
|
|
1823
State Street SPDR Portfolio Corporate Bond ETF
SPBO
$2.13B
| $995K | ﹤0.01% |
34,268
+1,496
| +5% | +$43.4K |
2023 Q3
11 quarters
|
|
1824
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.78B
| $995K | ﹤0.01% |
25,476
+19,092
| +299% | +$763K |
2025 Q3
3 quarters
|
|
1825
Resolute Holdings Management
RHLD
$944M
| $993K | ﹤0.01% |
6,868
+3,724
| +118% | +$484K |
2025 Q4
2 quarters
|
|
Similar funds
Corient Private Wealth's Q2 2026 Portfolio in Review
As of Q2 2026, Corient Private Wealth held 3,273 positions worth $72.2B, up 3.4% from $69.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Corient Private Wealth withdrew a net $6.91B in Q2 2026, closing 231 positions and reducing 1,294 holdings. Its most notable exit was Masimo, an estimated $57.2M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 37% a quarter earlier, followed by Technology and Financials.
Against the trend, Corient Private Wealth opened a new position in Powerlaw Corp worth $56.7M.
- Corient Private Wealth's largest Q2 2026 buy was Powerlaw Corp: 3,862,217 shares worth $56.7M.
- Corient Private Wealth added most to Invesco QQQ Trust in Q2 2026, an estimated $313M increase.
- Corient Private Wealth's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $449M.
- Corient Private Wealth fully exited Masimo in Q2 2026, selling an estimated $57.2M.
- Corient Private Wealth's ten largest holdings make up 27% of its $72.2B portfolio in Q2 2026.
- Corient Private Wealth opened 439 new positions and closed 231 in Q2 2026.
- Corient Private Wealth's portfolio value rose 3.4% quarter-over-quarter to $72.2B.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.